ARCHIVES

Gottlieb questions ODAC’s independence.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Cancer Meetings Listed For Next Three Months

September 20, 1996

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008